Document is current
Any future updates will be listed below
-
Authors
Loeffler, Chiara Maria Lavinia
El Nahhas, Omar S. M.
Muti, Hannah Sophie
Carrero, Zunamys I.
Seibel, Tobias
van Treeck, Marko
Cifci, Didem
Gustav, Marco
Bretz, Kevin
Gaisa, Nadine T.
Lehmann, Kjong-Van
Leary, Alexandra
Selenica, Pier
Reis-Filho, Jorge S.
Ortiz-Bruechle, Nadina
Kather, Jakob Nikolas https://orcid.org/0000-0002-3730-5348
-
Funding
Funding for this research was provided by:
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 8 January 2024
Accepted: 26 September 2024
First Online: 8 October 2024
Declarations
:
: The experiments in this study were carried out according to the Declaration of Helsinki and the International Ethical Guidelines for Biomedical Research Involving Human Subjects by the Council for International Organizations of Medical Sciences (CIOMS). The present study also adheres to the “Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis” (TRIPOD) statement.20. The Ethics Board at the Medical Faculty of Technical University Dresden (BO-EK-444102022) approved of the overall analysis in this study. The patient sample collection in each cohort was separately approved by the respective institutional ethics board.
: Not applicable.
: JNK reports consulting services for Owkin, France, Panakeia, UK, and DoMore Diagnostics, Norway, and has received honoraria for lectures by MSD, Eisai, and Fresenius. JSRF reports a leadership (board of directors) role at Grupo Oncoclinicas, stock or other ownership interests at Repare Therapeutics and Paige.AI, and a consulting or Advisory Role at Genentech/Roche, Invicro, Ventana Medical Systems, Volition RX, Paige.AI, Goldman Sachs, Bain Capital, Novartis, Repare Therapeutics, Lilly, Saga Diagnostics, Swarm and Personalis. No other potential conflicts of interest are reported by any of the authors.
